Hepatitis C Home > Pegasys Drug Information

Pegasys® (peginterferon alfa-2a) is a medication licensed for the treatment of chronic hepatitis B and C infections. It comes in the form of an injection that is given once a week just under the skin (subcutaneously) for 24 to 48 weeks. It is approved for treating hepatitis C in adults and children as young as five years old, and for hepatitis B in adults only.
While some people may not have any problems with this drug, most people will develop some type of side effect. Some of the most commonly reported problems include headaches, fatigue, and fever.
Before using Pegasys, make sure your healthcare provider has up-to-date information on any other drugs you are taking, including vitamins and supplements, as well as any allergies you may have, including to medications, foods, dyes, or preservatives. Also, let your healthcare provider know if you have certain medical issues, such as lung problems, diabetes, or depression.
(For more information, click Pegasys. This article provides information on how this drug works, dosing guidelines, and general safety precautions to be aware of before beginning treatment.)
Written by/reviewed by:
Last reviewed by: Arthur Schoenstadt, MD
Last updated/reviewed:
List of references (click here):
Other Articles in This eMedTV Presentation

Topics & Medications


Related Channels

eMedTV Links
Copyright © 2006-2020 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.